Families in Ghana still pay for maternal health services despite the country’s policy of free care.
Articles on Health insurance
Displaying 41 - 60 of 171 articles
Rather than finding efficiencies and saving money all around, the private companies that administer the Medicare Advantage option to Medicare are profiting at seniors’ – and taxpayers’ – expense.
While some policies have made the price of certain health care services more transparent, they don’t guarantee patients won’t be surprised by how much they’ll need to pay out of pocket.
Some private health insurers are offering their members easier access to GP telehealth services, sometimes for free.
Signing up for a Medicare plan when you turn 65 − or making changes in subsequent years – means wading through a thicket of consequential choices that can’t always be undone.
Patients often bear the cost of unexpected bills for basic preventive services such as wellness visits and cancer screenings.
Researchers found that nearly 74% of patients who reached out about a billing mistake received bill corrections. For those who negotiated their bills, nearly 62% saw a price drop.
New Zealand is not unique – health systems in most high-income countries are under stress. But that’s no reason to question the viability of the publicly-funded system in general.
When patients spend large sums on their cancer care, it can be hard for them to afford basics such as food and housing.
Knowing which kind of provider to see and how to access help can be half the battle.
Colon cancer is curable when caught early, but some insurers are either refusing to cover or significantly delaying approval for colonoscopies.
The way pharmacare is implemented could contribute to the Canadian health insurance system’s transition toward a more contentious and unequal American-style system with heavy administrative burdens.
Doctors are demanding the implementation of a 2017 agreement to improve working conditions.
We found rebates don’t do much to encourage older people to sign up for private health insurance.
Ghana’s public health insurance scheme was designed to provide basic care for all. But in reality those who would rather pay upfront than enrol get better treatment.
Access to economic and education opportunities increases women’s ability to withstand and recover from financial shocks.
The health coverage program’s enrollment soared during the three years after March 2020 due to temporary policies adopted at the start of the COVID-19 pandemic.
Changing workplace culture and the way jobs are designed can stave off depression, anxiety and burnout.
Discontinuing expanded health-care funding will result in less prenatal care for uninsured patients, more health risks, higher costs to the health system, and moral distress for health-care providers.
On the basis of government appointment technicalities and religious freedom, Americans may lose free coverage for cancer and blood pressure screenings, HIV prevention medication and other essential services.
Top contributors
-
Associate Professor of Public Health, The Ohio State University
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Professor of Health Finance, Weatherhead School of Management & School of Medicine, Case Western Reserve University
-
Professor of Health Economics, The University of Melbourne
-
Assistant Professor of Social, Behavioral and Population Sciences, Tulane University
-
Research scientist of Health Policy and Economics, University of Southern California
-
Research Scientist and Director of Research Training in Health Policy and Economics, University of Southern California
-
Assistant Professor of Health Policy and Management, UMass Amherst
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Karen Willis is a Friend of The Conversation.
Professor, Public Health, Victoria University, Victoria University
-
Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
-
Quintiles Professor of Pharmaceutical Development and Regulatory Innovation, Schaeffer Center for Health Policy and Economics, University of Southern California
-
Assistant Professor of Economics, University of California, Berkeley
-
Professor, Department of Health Policy, London School of Economics and Political Science